Kronos Bio Inc (KRON)

Currency in USD
0.880
+0.013(+1.50%)
Real-time Data·
Showing Kronos Bio historical data. For real-time data please try another search
Fair Value
Day's Range
0.8700.881
52 wk Range
0.6501.600
Key Statistics
Prev. Close
0.867
Open
0.881
Day's Range
0.87-0.881
52 wk Range
0.65-1.6
Volume
54.09K
Average Volume (3m)
855.67K
1-Year Change
-31.25%
Book Value / Share
1.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KRON Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Kronos Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Kronos Bio Inc Company Profile

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States. It is developing KB-9558, a p300 KAT inhibitor development candidate which is in preclinical development for the treatment of multiple myeloma, as well as HPV-driven tumors; and KB-7898, a p300 KAT inhibitor, which is in preclinical development for the treatment of Sjogren’s disease. The company was incorporated in 2017 and is headquartered in San Mateo, California. As of June 20, 2025, Kronos Bio, Inc. operates as a subsidiary of Concentra Biosciences, LLC.

Compare KRON to Peers and Sector

Metrics to compare
KRON
Peers
Sector
Relationship
P/E Ratio
−0.8x0.0x−0.5x
PEG Ratio
−0.020.000.00
Price/Book
0.7x0.0x2.6x
Price / LTM Sales
5.8x0.0x3.3x
Upside (Analyst Target)
158.6%0.0%42.4%
Fair Value Upside
Unlock0.0%7.2%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.14 / -0.30
Revenue / Forecast
1.86M / --
EPS Revisions
Last 90 days

KRON Income Statement

People Also Watch

0.687
WINT
-10.79%
4.8200
CLRB
+0.84%
574.93
NOC
+0.37%
0.170
NCL
-0.06%
2.865
VTYX
+6.52%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.